
51 - 200 employees
🧬 Biotechnology
💊 Pharmaceuticals
🔥 Funding within the last year
💰 $30M Post-IPO Secondary - DBV Technologies on 2025-10
Biotechnology • Pharmaceuticals
DBV Technologies is a global clinical-stage biopharmaceutical company developing epicutaneous immunotherapy to treat food allergies and other immune-mediated diseases. Founded by pediatricians, the company is advancing its proprietary VIASKIN® patch technology through clinical trials—including Phase 3 studies for a peanut allergy patch (DBV712) and earlier-stage programs for milk allergy (DBV135)—with the goal of re-educating the immune system using controlled skin exposure to antigens.
🕒 April 8
Improve your chances of getting an interview by checking your resume score before you apply.

51 - 200 employees
🧬 Biotechnology
💊 Pharmaceuticals
🔥 Funding within the last year
💰 $30M Post-IPO Secondary - DBV Technologies on 2025-10
Biotechnology • Pharmaceuticals
DBV Technologies is a global clinical-stage biopharmaceutical company developing epicutaneous immunotherapy to treat food allergies and other immune-mediated diseases. Founded by pediatricians, the company is advancing its proprietary VIASKIN® patch technology through clinical trials—including Phase 3 studies for a peanut allergy patch (DBV712) and earlier-stage programs for milk allergy (DBV135)—with the goal of re-educating the immune system using controlled skin exposure to antigens.
• Serve as lead for DBV relationship and B2B engagement with assigned accounts • Identify competitive threats and develop response strategies to ensure optimal access for products • Develop and own account-level plans for assigned national or regional payers, inclusive of formulary strategy, coverage policy objectives, and contracting priorities • Establish and maintain executive-level relationships with medical directors, pharmacy directors, and formulary committee decision-makers • Communicate the clinical, economic, and humanistic value of Viaskin® Peanut to payer audiences, translating HEOR data and real-world evidence into decision-relevant insights • Effectively articulate the differentiated profile of EPIT as a novel, non-invasive immunotherapy in a competitive and evolving food allergy treatment landscape • Anticipate and proactively address payer policy questions and potential coverage barriers prior to launch • Partner with patient services and hub operations to ensure reimbursement pathways are operationally aligned with payer coverage decisions • Represent market access in account-level business reviews and brand team planning cycles
• Bachelor’s Degree required; Advanced Degree preferred • A minimum of 10+ years of biotech/pharma of Market Access experience with prior leadership roles in account management and/or sales management • Must complete all required safety and certification training and must maintain an acceptable driving record regarding accidents and incidents • Requires greater than 50% travel • Experience integrating Health Economics and Medical Affairs resources into access planning • Demonstrated ability to collaborate with a diverse matrix of internal stakeholders (e.g., Market Access Account team, field sales, brand marketing, Medical, legal, compliance, Trade, Patient Services, Data & Analytics) to achieve access goals • Ability to identify future policies, practices and trends that will affect payer management and access decision making in the marketplace • Experience leading pull through efforts with sales leadership and field sales teams • Strong Market Access Payer and PBM (Commercial, and Managed Medicaid) understanding • Well-developed negotiation skills • A high level of awareness and understanding of the implications and opportunities of contract strategy • Experience identifying trends and insights and assimilating to development of a broader strategy • Maintain accurate account profiles and customer interactions via CRM.
Apply Now🕒 April 8
Director of Field Medical Affairs for Regeneron overseeing Neurology MSL teams and ensuring compliance. Collaborating with clinical staff and developing educational materials for healthcare professionals.
🇺🇸 United States – Remote
💵 $205k - $341.6k / year
💰 Post-IPO Equity on 2023-10
⏰ Full Time
🔴 Lead
👔 Director
🦅 H1B Visa Sponsor
🕒 April 8
Director of Engagement leading caregiver and patient engagement strategy for Ceresti Health. Driving initiatives for dementia care and maximizing caregiver participation and retention at scale.
🇺🇸 United States – Remote
🔥 Funding within the last year
💰 $11.7M Venture Round - Ceresti Health on 2025-08
⏰ Full Time
🔴 Lead
👔 Director
🕒 April 8
Corporate Affairs Director focusing on research communication strategies at Amgen. Developing and implementing strategic communication plans to elevate Amgen's position as a leader in scientific research and innovation.
🇺🇸 United States – Remote
💵 $180.6k - $244.3k / year
💰 $28.5G Post-IPO Debt on 2022-12
⏰ Full Time
🔴 Lead
👔 Director
🦅 H1B Visa Sponsor
🕒 April 8
Director of Strategy & Business Development driving organizational growth through government contracts and strategic partnerships in the aerospace ecosystem.
🕒 April 8
Director of System Implementations overseeing software implementations for healthcare technology company iCareManager. Managing a team and ensuring successful client onboarding experiences.